Drug application
CEFTAZIDIME (CEFTAZIDIME)
Drugs@FDA ANDA 065481 · AUROBINDO PHARMA LTD
Key facts
| Drug name | CEFTAZIDIME |
|---|---|
| Active ingredients | CEFTAZIDIME |
| Application type | ANDA |
| Application number | 065481 |
| Company | AUROBINDO PHARMA LTD |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 500MG/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | May 28, 2010 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.